Evidence map›Paper›PMID 34346775›Full record

ArticleHealth security

Assessment of Critical Care Surge Capacity During the COVID-19 Pandemic in Japan.

Takanori Yamamoto, Masayuki Ozaki, Daisuke Kasugai, Gilbert Burnham

Abstract read
In one paragraph

Article in Health security. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Observational
  3. Pediatric critical care capacity in Canada.Paediatrics & child health · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takanori YamamotoTakanori Yamamoto, MD, is an Assistant Professor; Masayuki Ozaki, MD, PhD, is a Visiting Scholar; and Daisuke Kasugai, MD, is an Assistant Professor; all in the Department of Emergency and Critical Care Medicine, Nagoya University Hospital, Nagoya, Japan. Masayuki Ozaki is also Director, Department of Intensive Care Unit, Komaki City Hospital, Komaki, Japan. Gilbert Burnham, MD, is a Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Masayuki OzakiTakanori Yamamoto, MD, is an Assistant Professor; Masayuki Ozaki, MD, PhD, is a Visiting Scholar; and Daisuke Kasugai, MD, is an Assistant Professor; all in the Department of Emergency and Critical Care Medicine, Nagoya University Hospital, Nagoya, Japan. Masayuki Ozaki is also Director, Department of Intensive Care Unit, Komaki City Hospital, Komaki, Japan. Gilbert Burnham, MD, is a Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Daisuke KasugaiTakanori Yamamoto, MD, is an Assistant Professor; Masayuki Ozaki, MD, PhD, is a Visiting Scholar; and Daisuke Kasugai, MD, is an Assistant Professor; all in the Department of Emergency and Critical Care Medicine, Nagoya University Hospital, Nagoya, Japan. Masayuki Ozaki is also Director, Department of Intensive Care Unit, Komaki City Hospital, Komaki, Japan. Gilbert Burnham, MD, is a Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Gilbert BurnhamTakanori Yamamoto, MD, is an Assistant Professor; Masayuki Ozaki, MD, PhD, is a Visiting Scholar; and Daisuke Kasugai, MD, is an Assistant Professor; all in the Department of Emergency and Critical Care Medicine, Nagoya University Hospital, Nagoya, Japan. Masayuki Ozaki is also Director, Department of Intensive Care Unit, Komaki City Hospital, Komaki, Japan. Gilbert Burnham, MD, is a Professor, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Japan has the highest proportion of older adults worldwide but has fewer critical care beds than most high-income countries. Although the COVID-19 infection rate in Japan is low compared with Europe and the United States, by the end of 2020, several infected people died in ambulances because they could not find hospitals to accept them. Our study aimed to examine the Japanese healthcare system's capacity to accommodate critically ill COVID-19 patients during the pandemic. We created a model to estimate bed and staff capacity at 3 levels of pandemic response (conventional, contingency, and crisis), as defined by the US National Academy of Medicine, and the function of Japan's healthcare system at each level. We then compared our estimates of the number of COVID-19 patients requiring intensive care at peak times with the national health system capacity using expert panel data. Our findings suggest that Japan's healthcare system currently can accommodate only a limited number of critically ill COVID-19 patients. It could accommodate the surge of pandemic demands by converting nonintensive care unit beds to critical care beds and using nonintensive care unit staff for critical care. However, bed and staff capacity should not be expanded uniformly, so that the limited number of physicians and nurses are allocated efficiently and so staffing does not become the bottleneck of the expansion. Training and deploying physicians and nurses to provide immediate intensive care is essential. The key is to introduce and implement the concept and mechanism of tiered staffing in the Japanese healthcare system. More importantly, most intensive care facilities in Japanese hospitals are small-scaled and thinly distributed in each region. The government needs to introduce an efficient system for smooth dispatching of medical personnel among hospitals regardless of their founding institutions.

Indexed as

COVID-19Surge CapacityAgedCritical CareHumansIntensive Care UnitsJapanPandemicsSARS-CoV-2United StatesCOVID-19Critical care bedsMedical management/responsePublic health preparedness/response

Identifiers

PMID34346775
PMCPMC10818035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.